$3.25 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 56 reported holdings in Q1 2013. The portfolio turnover from Q4 2012 to Q1 2013 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q1 2013 |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-05-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BIOMARIN PHARMAC INC | 45 | Q2 2024 | 6.7% |
DR REDDYS LABS LTD | 45 | Q2 2024 | 2.0% |
PTC THERAPEUTICS INC | 43 | Q2 2024 | 2.7% |
GILEAD SCIENCES INC | 41 | Q2 2024 | 8.4% |
VERTEX PHARMACEUTICL | 41 | Q2 2024 | 6.0% |
INCYTE CORPORATION | 41 | Q2 2024 | 5.2% |
AMICUS THERAPEUTICS INC | 40 | Q2 2024 | 6.6% |
PFIZER INC | 38 | Q2 2024 | 6.3% |
MERCK & CO. INC | 37 | Q2 2024 | 6.4% |
MEDTRONIC PLC | 36 | Q2 2024 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
eFFECTOR Therapeutics, Inc. | February 14, 2024 | 2,382,644 | 3.7% |
Galera Therapeutics, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
SEQUENOM INC | February 12, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-08-13 |
N-PX | 2024-08-09 |
13F-HR | 2024-05-14 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
SC 13G/A | 2023-02-13 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.